ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Phase 3 Immunogenicity and Safety Study of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

This study is ongoing, but not recruiting participants.
Study NCT00462215.   Last updated on January 24, 2008.   Information provided by Baxter Healthcare Corporation
Please refer to this study by its ClinicalTrials.gov identifier: NCT00462215


Locations
Austria
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna    
      Vienna, Austria, 1090
Germany
University Hospital Mainz    
      Mainz, Germany, 55101

Sponsors and Collaborators
Baxter Healthcare Corporation

Investigators
Principal Investigator:     Baxter BioScience Investigator, MD     Baxter Healthcare Corporation    


U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act
U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services



Links to all studies - primarily for crawlers